Breaking Free from Commercial Limitations with Custom Chemical Synthesis
In the vast landscape of pharmaceutical research and development, one significant challenge that researchers face is the availability of suitable
Read moreIn the vast landscape of pharmaceutical research and development, one significant challenge that researchers face is the availability of suitable
Read moreVarda Space Industries, a California-based startup, is venturing into the realm of pharmaceutical manufacturing in microgravity with the goal of
Read moreCoya Therapeutics’ investigational low-dose interleukin-2 (IL-2) for subcutaneous administration, COYA 301, has been found to increase Treg function and halt
Read moreEisai Co., Ltd. revealed that it has partnered with Bliss Biopharmaceutical (Hangzhou) Co., Ltd. to develop BB-1701, an antibody-drug conjugate
Read moreOri Biotech, based in the United Kingdom, has secured €88 million ($100 million) in its Series B funding to help
Read moreFrench pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read moreGenentech’s investigational antibody for the treatment of early-stage Alzheimer’s disease, Gantenerumab, has been granted Breakthrough Therapy Designation by the U.S.
Read moreTezepelumab, developed by AstraZeneca in collaboration with Amgen, has been granted Orphan Drug Designation (ODD) in the US FDA for
Read moreTakeda and JCR Pharmaceuticals announced today a geo-based exclusive collaboration and license agreement to commercialize JR-141 (INN: pabinafusp alfa), an
Read more